| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
VK
|
18.63 | 5.0B | 3.07 | 1.75 | 1.36 | 14.3% | 10.6% | 80 | 65 | 40.47 | +87.9% | 83 | 0.38 |
|
VCT
|
64.50 | 2.9B | 2.48 | 0.95 | 1.48 | 7.9% | 8.7% | 79 | 66 | 151.37 | +101.0% | 68 | 0.60 |
|
ERA
|
45.32 | 1.3B | — | 2.93 | 4.14 | -1.2% | 6.2% | 28 | 29 | 23.73 | -20.5% | 47 | 7.07 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.